Abstract
Large scale analysis of gene expression using DNA arrays shows great promise in enhancing our understanding of how the genome constructs the brain. This technology has been employed to analyze gene expression variations in the brain resulting from genetic polymorphisms, drug abuse, aging, and the neuropsychiatric disorders such as schizophrenia and Alzheimers disease. Although the data from DNA array analysis is necessarily noisy, thoughtfully designed experiments can give useful insights. In addition, as the use of DNA array technology grows, replicated experiments will provide even greater confidence in drawn conclusions, giving optimism that these methods will yield profound insights into the genomics of the brain.
Keywords: gene expression, phychosis genes, alzheimers disease, anti-apoptosis, aging, genomic
Current Genomics
Title: Chips for Brains
Volume: 3 Issue: 1
Author(s): D. J. Smith
Affiliation:
Keywords: gene expression, phychosis genes, alzheimers disease, anti-apoptosis, aging, genomic
Abstract: Large scale analysis of gene expression using DNA arrays shows great promise in enhancing our understanding of how the genome constructs the brain. This technology has been employed to analyze gene expression variations in the brain resulting from genetic polymorphisms, drug abuse, aging, and the neuropsychiatric disorders such as schizophrenia and Alzheimers disease. Although the data from DNA array analysis is necessarily noisy, thoughtfully designed experiments can give useful insights. In addition, as the use of DNA array technology grows, replicated experiments will provide even greater confidence in drawn conclusions, giving optimism that these methods will yield profound insights into the genomics of the brain.
Export Options
About this article
Cite this article as:
Smith J. D., Chips for Brains, Current Genomics 2002; 3 (1) . https://dx.doi.org/10.2174/1389202023350651
DOI https://dx.doi.org/10.2174/1389202023350651 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Effects of ACE Inhibitors on Skeletal Muscle
Current Pharmaceutical Design Editorial (Forward Look: Tenth Anniversary of the Human Genome Sequence and 21st Century Postgenomics Global Health - A Close Up on Africa and Womens Health)
Current Pharmacogenomics and Personalized Medicine Ideational Fluency in Patients with Rheumatoid Arthritis
Current Rheumatology Reviews Human Embryonic Stem Cell-Derived Cardiomyocytes for Heart Therapies
Cardiovascular & Hematological Disorders-Drug Targets MicroRNA Regulation in Cardiovascular Disease
Current Drug Targets Atrial Fibrillation: The Emerging Role of Inflammation and Oxidative Stress
Cardiovascular & Hematological Disorders-Drug Targets Genetic and Non-genetic Determinants of Cardiovascular Disease in South Asians
Current Diabetes Reviews Meet Our Editorial Board Member
Current Drug Delivery Collateral Circulation in Chronic Total Occlusions – an interventional perspective
Current Cardiology Reviews Non Alcoholic Fatty Liver: Epidemiology and Natural History
Reviews on Recent Clinical Trials Pre-procedural Elevated White Blood Cell Count and Neutrophil-Lymphocyte (N/L) Ratio are Predictors of Ventricular Arrhythmias During Percutaneous Coronary Intervention
Cardiovascular & Hematological Disorders-Drug Targets The Janus Face of Adenosine: Antiarrhythmic and Proarrhythmic Actions
Current Pharmaceutical Design Altered Prolylcarboxypeptidase Expression and Function in Response to Different Risk Factors of Diabetes
Cardiovascular & Hematological Agents in Medicinal Chemistry MicroRNAs as Candidate Drug Targets for Cardiovascular Diseases
Current Drug Targets Nutrigenomics and Personalized Diet: What are the Anticipated Impacts for Research on Chronic Diseases and Public Health?
Current Pharmacogenomics and Personalized Medicine The mTOR Signaling Network: Insights from Its Role During Embryonic Development
Current Medicinal Chemistry Novel Ligands: Fine Tuning the Transcriptional Activity of the Glucocorticoid Receptor
Current Pharmaceutical Design Epigenetic control of cardiovascular health by nutritional polyphenols involves multiple chromatin-modifying writer-reader-eraser proteins
Current Topics in Medicinal Chemistry Role of Sympathetic Nerve Activity in Obesity, Hypertension and Metabolic Syndrome
Current Hypertension Reviews Metaflammation: Tissue-Specific Alterations of the NLRP3 Inflammasome Platform in Metabolic Syndrome
Current Medicinal Chemistry